Alexion Reports First Quarter 2017 Results
Alexion Pharmaceuticals, Inc (ALXN)
Last alexion pharmaceuticals, inc earnings: 1/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.alexion.com/investor-relations
Company Research
Source: Business Wire
1Q17 Total Revenues of $870 Million, a 24% Increase and 26% Volume Increase Year-Over-Year Revenue Growth Benefited from Continued Strong Volume Growth of Soliris® In Core Markets Strensiq® Revenue Driven by Steady Addition of New Patients Starting Treatment Applications Filed in U.S., Europe and Japan for Soliris in Patients with Refractory gMG Enrollment in ALXN1210 Phase 3 Studies Advanced in Patients with PNH and aHUS New Phase 1 Data Support Advancing Development of ALXN1210 Subcutaneous Formulation Reiterating 2017 Revenue Guidance of $3.4 to $3.5 Billion and Increasing GAAP EPS Guidance to $2.80 to $3.20 per share and Non-GAAP EPS Guidance to $5.10 to $5.30 per share NEW HAVEN, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial
Show less
Read more
Impact Snapshot
Event Time:
ALXN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALXN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALXN alerts
High impacting Alexion Pharmaceuticals, Inc news events
Weekly update
A roundup of the hottest topics